X4 Pharmaceuticals, Inc reports

Company location: Boston, MA
Fiscal year end: 31 December

X4 Pharmaceuticals, Inc has filed 800 SEC EDGAR filings since 24 Sep 2010

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 576-600 of 800 matching filings.

Per page

Current page

8-K File 001-38295

8-K

Filing date: 04 Oct 2019
Reporting date: 03 Oct 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38295

8-K

Filing date: 30 Sep 2019
Reporting date: 30 Sep 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 20 Sep 2019
Reporting date: 18 Sep 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 3 SUBMISSION

Filing date: 20 Sep 2019
Reporting date: 18 Sep 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38295

8-K

Filing date: 20 Sep 2019
Reporting date: 18 Sep 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-233161

EFFECT filing

Filing date: 29 Aug 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 27 Aug 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3/A File 333-233161

S-3/A

Filing date: 22 Aug 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 22 Aug 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 14 Aug 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-233162

S-8

Filing date: 09 Aug 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3 File 333-233161

S-3

Filing date: 09 Aug 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38295

8-K

Filing date: 09 Aug 2019
Reporting date: 09 Aug 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38295

10-Q

Filing date: 07 Aug 2019
Reporting date: 30 Jun 2019
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13D/A File 005-90199

SC 13D/A

Filing date: 17 Jul 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38295

8-K

Filing date: 28 Jun 2019
Reporting date: 27 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38295

8-K

Filing date: 26 Jun 2019
Reporting date: 26 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38295

8-K

Filing date: 19 Jun 2019
Reporting date: 17 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 19 Jun 2019
Reporting date: 17 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 19 Jun 2019
Reporting date: 17 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 19 Jun 2019
Reporting date: 17 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 19 Jun 2019
Reporting date: 17 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-90199

NEW ENTERPRISE ASSOCIATES 16, L.P. - X4 PHARMACEUTICALS, INC. 13D/A1

Filing date: 28 May 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-38295

DEF 14A

Filing date: 22 May 2019
Reporting date: 17 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K/A File 001-38295

8-K/A

Filing date: 17 May 2019
Reporting date: 29 Mar 2019
SEC evidence: Open document Open filing
Next action: Verify source filing